INTRODUCTION {#sec01}
============

The marine medaka, *Oryzias dancena*(Beloniformes; Teleostei), is a euryhaline teleost that mainly inhabits the brackish or freshwater of river mouths and estuaries around Bengal Bay and the Malay Peninsula ([@B22])*.* It also has a short interval between generations, with spawning possibilities just 60 days after hatching ([@B11]; [@B5]). Most of its physiological attributes are similar across a wide spectrum of salinities, ranging from complete freshwater to normal seawater ([@B8]; [@B9]; [@B5]). The marine medaka isn't indigenous to Korea. However, this species is accredited by the Ministry of Land, Transport and Maritime Affairs, Korea (Ordinance of Agriculture, Food and Fisheries, No. 1) and is imported legally from Indonesia ([@B11], [@B12]). Recently, the Institute of Marine Living Modified Organisms (*i*MLMO) selected this species for a living modified organism evaluation project. In line with this purpose, detailed information on marine medaka biology has begun to be exploited, especially regarding early gonadogenesis, sex differentiation, early ontogenesis, and embryogenesis ([@B11], [@B12]). In addition, [@B15] researched tolerance capacity to salinity changes in this species. This species is highly capable of hyper-osmoregulation as well as hypo-osmoregulation. Also, no marine medaka in the experimental group (0 to 40 ppt) died from stress of salinity changes ([@B15]).

An effective high-density transport method for fish is essential to minimize stress and reduce the chance of mass mortality ([@B3]) during long periods of transportation and handling, and to reduce expenses and avoid losses ([@B3]; [@B25]). The production of new equipment and transport procedures has had increasingly positive effects on the transportation of live fish. In addition, anesthetics are also effective method of transporting fish. Because, the use of anesthetics in aquaculture reduces fish energy, allowing for the efficient transportation of fish, ease of handling when measurements are taken, a reduction in the pain and trauma experienced by experimental fish, and reduced handling stress ([@B21]; [@B4]). For example, the use of nonpoisonous salt has been shown to alleviate stress and promote higher survival rates ([@B27]; [@B2]; [@B1]; [@B4]). The use of low-concentration calcium chloride is a cheap and effective method of handling and transporting live fish ([@B6]; [@B1]).

In recent years, [@B19] reported that anesthe-tic effect by changing water temperature (cold shock and heat shock). Temperature shock anesthesia in fish is characterized by an absence of motion, reduced power of exertion, and diminished nervous sensitivity. Temperature shock anesthesia is reversible and leaves no residue in the tissues. No danger is imposed to the user, other than the risk inherent in handling solid carbon dioxide if that material is used ([@B19]). But temperature shock anesthesia has short anesthetic time for handling samples. Mass mortality of samples may cause by this method, because process of this method is to faint by temperature shock. Therefore, based on the fact that it is safe, inexpensive, non-toxic to the environment and stable, and does not require a withdrawal period compared to other synthetic-based anesthetics, the use of clove oil and lidocaine-HCl has become more popular in the aquaculture industry ([@B10]; [@B20]). The effects of clove oil and lidocaine-HCl as anesthetics have been studied in a number of fish species ([@B28]; [@B16], [@B21], [@B20]; [@B4]).

However, previous research on marine medaka has investigated the effects of anesthetic clove oil and lidocaine-HCl on water temperature and anesthetic effects of changing water temperature and stress responses in the marine medaka ([@B20]; [@B19]). No previous research has investigated the anesthetic effects of clove oil and lidocaine-HCl on the marine medaka during transportation. We have determined the aim of this research should concern a euryhaline teleost, so the marine medaka was chosen. The aim of this study was to determine optimum concentrations of anesthetic clove oil and anesthetic lidocaine-HCl for the marine medaka in various salinity conditions, and analyzing various physiological and water parameters by a simulation experiment in optimum salinity condition.

MATERIALS AND METHODS {#sec02}
=====================

1. Fish production and sampling {#sec02-01}
-------------------------------

On 12 January 2009, 30 specimens of adult marine medaka, *Oryzias dancena*were obtained from *i*MLMO, Pukyung National University, Korea. The fish were reared and bred in the Fishery Genetics and Breeding Sciences Laboratory of the Korea Maritime University. Ten thousand specimens of adult marine medaka were bred from the original 30 specimens in 11 months. The marine medaka used in the study were selected at random from the entire population. Samples were measured using an electronic balance (Shimadzu, Japan) and vernier caliper (Mitutoyo, Japan). Average body length and body weight of the group were 30.8±3.52 mm (*n* = 50) and 334.9±60.04 mg (*n* = 50), respectively.

2. Condition of anesthesia {#sec02-02}
--------------------------

The anesthetic experiment began on 29 December 2015 and ended on 20 February 2016. Fifty specimens from each of the groups were randomly selected for respective experiment to investigate the anesthetic effects of clove oil (Sigma, USA) and lidocaine-HCl (Hongsung Chemical, Korea). Five water salinities, 0, 10, 20, 30, and 40 ppt, were set for the study and anesthetic water salinity was identical with recovery water salinity. Water salinity of each group was regulated to be same as the anesthetic water salinity during the experiment. Until experiment termination, the water temperature was maintained at 26℃. All the fish were deprived of food for 24 hours before the study. The study methods for the anesthetic effect of clove oil and lidocaine were taken from the methods of [@B20]. Furthermore, all experiments were completed in duplicate.

3. Criteria of anesthetic effect {#sec02-03}
--------------------------------

The decision-based anesthetic effect table shows the stages of anesthesia and recovery that were used as endpoints (only opercular movement: A6; normal swimming, responsiveness to visual stimuli: R6) in the present study ([@B26]; [@B29]; [@B20]). During this experiment, anesthetizing marine medaka involved several stages, from slowed swimming speed and side to side rolling (stage A2) to only opercular movement (stage A6). At stage A6, individuals were transferred to a recovery tank. Recovery time was established as the point at which erratic swimming began. Recovery time included redressing the balance (stage R5) and normal swimming, as well as responsiveness to visual stimuli (stage R6).

4. Respiratory frequency {#sec02-04}
------------------------

After anesthetic experiment, a simple sealed container, comprising an acrylic resin box with a wall thickness of 8 mm and overall dimensions of 10 cm (width)×50 cm (length)×10 cm (height), was used as a respirometer chamber. The hose for the inflow water was equipped with a temperature controller and 10 µm and 3 µm cartridge filters to exclude any particles. A flow-through ultraviolet lamp was used to reduce the oxygen consumption by microbes. The temperature of the water flowing into the respirometer chamber was maintained at 26±0.3℃ with a heater. The water salinity was maintained optimum anesthetic salinity by brackish water, and optimum anesthetic salinity of each group were analyzed by anesthetic experiment. The respirometer chambers were prepared and labeled according to the measurement times and anesthetic concentrations.

5. Criteria of water parameter effect {#sec02-05}
-------------------------------------

For determine the appropriate experimental concentrations of clove oil and lidocaine-HCl, we performed a pilot experiment for 48 hours. To prevent mortality in the experimental sample, the anesthetized marine medaka were maintained at several levels of anesthesia during the pilot study, ranging from normal swimming, opercular movement, and general movement (stage A1) to slow swimming and side-to-side rolling (stage A2) ([@B26]; [@B29]; [@B20]). The anesthetic effects of clove oil were determined at five concentrations: 0.2, 0.4, 0.6, 0.8, and 1 ppm. The stock solution of clove oil was dissolved in 95% methanol (Sigma, St. Louis, USA) at a ratio of 1:10. The effects of lidocaine-HCl were determined at five concentrations: 20, 40, 60, 80, and 100 ppm. To neutralize the anesthetic solution (lidocaine-HCl solution) and to amplify its effect ([@B20]), Na-HCO~3~ (Sigma, St. Louis, USA) at a total concentration of 1,000 ppm was added to the solution.

6. Water parameter in anaesthetic experiment {#sec02-06}
--------------------------------------------

Measurements were made at 6 hours intervals after experiment was begun, for 48 hours. Before the dissolved oxygen (DO) was measured, the concentrations of ammonium (NH~4~^+^) and carbon dioxide (CO~2~) were measured with a spectrophotometer (DR2800, HACH, Loveland, Colorado, USA) and the respiratory frequencies (gill cover movements) of the fish were measured with a counter and a digital timer. DO was measured with an oxygen electrode and a multidata logger system (Oxyguard, Denmark).

7. Statistical analysis {#sec02-07}
-----------------------

The data were analyzed with one- and two-way ANOVA with the SPSS statistical package (SPSS 9.0, SPSS Inc., USA). Differences between means were evaluated with Duncan's multiple range test and considered significantly different at *P\<*0.05.

RESULTS {#sec03}
=======

No fish died from stress due to anesthesia during this anesthetic experiment. [Table 1](#T1){ref-type="table"} shows the anesthetic effects of clove oil at each concentration and water salinity. Anesthetic time was significantly affected by water salinity and clove oil concentrations, and decreased drastically as the concentration of clove oil increased (*P\<*0.05). However, the anesthetic effects on water salinity show a different trend. Anesthesia times increased in the other salinities excepted for 0 ppt. Furthermore, at each salinity concentration, the anesthetic time at 10 ppt was faster than the other salinities. In addition, the pattern of recovery time was similar to that of anesthetic time (*P\<*0.05). With the exception of 0 ppt, recovery time increased gradually at all other salinities. At 10 ppt, the recovery time at each salinity concentration was faster than the other salinities. It is important to note that the recovery times of clove oil in each concentration were similar that each salinity. [Fig. 1](#F1){ref-type="fig"} shows the concentration of clove oil and the ratios of recovery times in relation to anesthesia time relative to the water salinity. In terms of trends, the ratio of recovery time to anesthesia time gradually increased as clove oil concentration increased at each water salinity group (*P\<*0.05). However, at each clove oil concentration, the ratio of the recovery time to anesthesia time in relations to the water salinity decreased with the exception of 75 ppm (*P\<*0.05).

###### Effects of clove oil dose and starting water salinity on anesthesia among marine medaka, *Oryzias dancena*

  Dose(mgL^-1^)                   Exposure time (sec)^\*^                                                       
  ------------------------------- ------------------------- ---------------- ---------------- ----------------- ----------------
  50                              160.0±9.43^b^             126.6±11.02^a^   206.0±19.83^c^   218.6±40.25^d^    226.4±39.10^e^
  75                              138.4±8.28^b^             83.0±18.38^a^    154.7±16.46^c^   159.9±39.76^d^    164.3±17.24^e^
  100                             100.8±4.29^b^             61.5±5.52^a^     108.9±6.31^c^    112.2 ±15.75^d^   120.4±7.88^e^
  125                             73.5±12.61^b^             52.1±4.91^a^     80.9±11.59^c^    85.2±6.61^d^      90.9±8.97^e^
  150                             50.1±6.06^a^              44.2±2.94^a^     62.9±4.93^b^     62.8±8.93^b^      73.8±9.77^c^
  Dose(mgL^-1^)                   Recovery time (sec)^\*^                                                       
  0 ppt                           10 ppt                    20 ppt           30 ppt           40 ppt            
  50                              185.0±26.94^c^            133.2±14.81^a^   163.2±26.33^b^   160.8±20.84^b^    159.1±21.48^b^
  75                              188.5±29.02^d^            125.7±18.49^a^   155.7±15.10^b^   145.9±16.04^c^    145.8±18.59^c^
  100                             196.5±22.98^c^            116.7±13.28^a^   146.7±21.73^b^   145.6±20.58^b^    146.2±20.05^b^
  125                             193.8±34.00^d^            123.5±20.38^a^   143.5±20.97^b^   151.9±13.03^bc^   152.1±12.04^c^
  150                             175.6±33.94^d^            131.3±9.20^a^    157.4±12.10^b^   151.3±14.33^c^    157.5±13.20^b^
  Two-way ANOVA (exposure time)                                                                                 
                                  DF                        Anova SS         Mean square      *F*-value         *P*-value
  Salinity                        4                         30,475.440       7,618.860        26.055            \<0.0001
  Dose                            4                         618,919.0        154,729.7        529.150           \<0.0001
  Interaction                     16                        12,833.400       802.087          2.743             \<0.0001
  Two-way ANOVA (recovery time)                                                                                 
                                  DF                        Anova SS         Mean square      *F*-value         *P*-value
  Salinity                        4                         48,654.896       12,163.724       29.521            \<0.0001
  Dose                            4                         5,557.856        1,389.464        3.372             \<0.0110
  Interaction                     16                        9,551.864        596.992          1.449             \<0.1210

^\*^Each value is mean±standard error of duplicate experiments. Values in the same column not sharing common superscripts are significantly different (*P*\<0.05).

![Effect of clove oil dose and water salinity on the ratio of recovery time/exposure time among marine medaka, *Oryzias dancena*.\
Error bar represents the standard error of duplicate experiments. Different letters on the bars indicate statistical significance (*P*\<0.05).](dr-21-1-19-g1){#F1}

[Table 2](#T2){ref-type="table"} shows the anesthetic effects of lidocaine-HCl at each concentration and water salinity. At each salinity, the anesthesia time decreased drastically as the concentration of lidocaine-HCl increased (*P\<*0.05). The anesthesia time increased as water salinity increased between 200 ppm and 400 ppm. At other concentrations, the pattern of lidocaine-HCl was similar to that of clove oil. Recovery time exhibitted a similar pattern, but the anesthesia time pattern differed. As the concentration of lidocaine-HCl increased, recovery time at each concentration decreased at each salinity group. At 0 ppt, the recovery time at each concentration was slower than at any other salinity. However, at 10 ppt, the recovery time was faster than at any other salinity. At water salinities over 20 ppt, recovery time decreased as water salinity increased (*P\<*0.05).

###### Effects of lidocaine-HCl dose and starting water salinity on anesthesia among marine medaka, *Oryzias dancena*

  Dose(mgL^-1^)                   Exposure time (sec)^\*^                                                        
  ------------------------------- ------------------------- ----------------- ---------------- ----------------- ----------------
  200                             250.1±14.90^a^            313.3±12.43^b^    323.8±38.75^c^   397.4±95.78^d^    396.1±63.49^d^
  300                             182.4±21.25^a^            255.8±29.20^b^    255.2±33.69^b^   260.9±39.18^bc^   263.0±30.29^c^
  400                             150.0±33.78^a^            170.1±17.76^b^    187.9±15.38^c^   200.9±27.14^d^    199.0±16.46^d^
  500                             110.4±15.46^b^            105.3±32.22^a^    158.9±28.97^c^   167.1±23.27^c^    167.9±28.31^c^
  600                             83.0±15.32^a^             82.4±28.19^a^     134.9±27.12^b^   134.8±16.75^b^    138.8±43.29^c^
  700                             76.0±16.63^b^             62.4±15.66^a^     95.6±35.76^c^    99.5±0 9.14^c^    101.5±34.31^d^
  800                             57.0±8.91^b^              47.6±7.21^a^      74.7±12.05^c^    76.6±0 4.86^c^    78.7±17.18^c^
  Dose(mgL^-1^)                   Recovery time (sec)^\*^                                                        
  0 ppt                           10 ppt                    20 ppt            30 ppt           40 ppt            
  200                             379.0±35.45^d^            208.2±20.83 ^a^   330.0±37.33^c^   310.4±39.40^b^    308.2±58.47^b^
  300                             350.0±24.81^d^            234.4±131.83^a^   320.5±73.06^c^   305.2±34.50^b^    300.5±40.80^b^
  400                             327.2±68.13^d^            260.5±169.29^a^   280.5±48.56^c^   272.2±38.34^b^    270.4±84.46^b^
  500                             325.4±68.10^d^            214.0±92.94^a^    238.5±38.07^c^   223.8±35.34^b^    220.1±53.95^b^
  600                             325.8±156.61^b^           168.7±179.91^a^   169.8±29.72^a^   171.1±20.71^a^    170.0±33.56^a^
  700                             323.3±67.40^c^            146.9±56.28^a^    167.0±43.54^b^   166.8±31.70^b^    166.9±40.39^b^
  800                             322.1±60.25^c^            129.6±70.31^a^    132.3±20.15^b^   133.1±15.88^b^    132.5±24.74^b^
  Two-way ANOVA (exposure time)                                                                                  
                                  DF                        Anova SS          Mean square      *F*-value         *P*-value
  Salinity                        4                         179,621.5         4,905.379        46.625            \<0.0001
  Dose                            6                         2,583,927         430,654.5        447.147           \<0.0001
  Interaction                     24                        92,106.646        3,837.777        3.985             \<0.0001
  Two-way ANOVA (recovery time)                                                                                  
                                  DF                        Anova SS          Mean square      *F*-value         *P*-value
  Salinity                        4                         638,164.1         159,541.0        52.927            \<0.0001
  Dose                            6                         1,248,225         208,037.6        69.016            \<0.0001
  Interaction                     24                        191,254.8         7,968.949        2.644             \<0.0001

^\*^ Each value is mean±standard error of duplicate experiments. Values in the same column not sharing common superscripts are significantly different (*P*\<0.05).

[Fig. 2](#F2){ref-type="fig"} shows the concentrations of lidocaine-HCl and recovery time ratios in relation to anesthesia time according to water salinity. In terms of trends, the ratio of recovery time to anesthesia time gradually increased as the lidocaine-HCl concentration increased at each water salinity group (*P\<*0.05). However, at each lidocaine-HCl concentration, the ratios of recovery time to anesthesia time according to water salinity were different from the clove oil trend. At 0 ppt, the ratio of recovery time to anesthesia time was higher than other salinities. Moreover, at all salinities excepted for 0 ppt, the ratios of t recovery time to anesthesia time were similar (*P\<*0.05).

![Effect of lidocaine-HCl dose and water salinity on the ratio of recovery time/exposure time among marine medaka, *Oryzias dancena*.\
Error bar represents the standard error of duplicate experiments. Different letters on the bars indicate statistical significance (*P*\<0.05).](dr-21-1-19-g2){#F2}

At each concentration of clove oil and lidocaine-HCl, fish were anesthetized slower at water salinities over 10 ppt. Anesthesia time at 10 ppt was faster than at any other salinity. With the exception of 10 ppt, relationships between water salinity and anesthesia time presented a positive gradual curve, with increased water salinity (over 10 ppt) resulting in increased anesthesia time. Such a proportional relationship has not been found in previous studies. For this species, lower salinity resulted in significantly shorter anesthesia induction from clove oil and lidocaine-HCl (*P\<*0.001).

The results for the DO concentrations, the respiratory frequencies, and the NH~4~^+^ and CO~2~ concentrations in the clove-oil-administered groups are presented in [Tables 3](#T3){ref-type="table"}, [4](#T4){ref-type="table"}, and [5](#T5){ref-type="table"} and [Fig. 3](#F3){ref-type="fig"}, respectively. The DO concentrations and the respiratory frequencies decreased in all the experimental groups up to 48 hours (*P\<*0.05; [Tables 3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}, respectively), whereas the NH~4~^+^ and CO~2~ concentrations in all the experimental groups increased up to 48 hours (*P\<*0.05; [Table 5](#T5){ref-type="table"} and [Fig. 3](#F3){ref-type="fig"}, respectively). At 6 hours, both the DO and NH~4~^+^ concentrations and the respiratory frequencies had decreased with increasing clove oil concentrations (all *P\<*0.05). At 6 hours, CO~2~ was 12.1±2.83 ppm for the control group, 10.5±3.35 ppm for the 0.2 ppm clove oil group, 9.2±2.13 ppm for the 0.4 ppm clove oil group, 8.4±2.01 ppm for the 0.6 ppm clove oil group, 7.7±1.99 ppm for the 0.8 ppm clove oil group, and 7.5±1.97 ppm for the 1 ppm clove oil group. At 12 hours, the DO, NH~4~^+^, and CO~2~ concentrations and respiratory frequencies had decreased with increasing clove oil concentrations. The CO~2~ concentration at 12 hours was 15.4±2.95 ppm for the control group, 14.7±2.59 ppm for the 0.2 ppm clove oil group, 14.2±2.67 ppm for the 0.4 ppm clove oil group, 13.7±3.54 ppm for the 0.6 ppm clove oil group, 12.9±2.44 ppm for the 0.8 ppm clove oil group, and 12.2±1.75 ppm for the 1 ppm clove oil group. At all other times (18, 24, 30, 36, 42, and 48 hours), the trends in the DO, NH~4~^+^, and CO~2~ concentrations and the respiratory frequencies for the control and clove-oil-administered groups were similar to those at 6 and 12 hours.

###### Dissolved oxygen concentrations during clove-oil-induced anesthesia in the marine medaka, *Oryzias dancena*, in a simulated transport experiment

  Exposuretime (hours)   Dose (mgL^-1^)\*                                                               
  ---------------------- ------------------ -------------- -------------- -------------- -------------- --------------
  6                      6.51±0.83^a^       6.65±0.79^b^   6.77±0.64^c^   6.85±0.71^d^   6.98±0.72^e^   7.41±0.79^f^
  12                     6.04±0.79^a^       6.16±0.51^b^   6.23±0.48^c^   6.37±0.54^d^   6.46±0.45^e^   6.58±0.66^f^
  18                     5.46±0.94^a^       5.55±0.88^b^   5.64±0.55^c^   5.77±0.57^d^   5.87±0.64^e^   5.99±0.89^f^
  24                     5.01±0.75^a^       5.12±0.43^b^   5.22±0.37^c^   5.31±0.66^d^   5.46±0.81^e^   5.58±0.75^f^
  30                     4.67±0.92^a^       4.78±0.52^b^   4.88±0.49^c^   4.97±0.43^d^   5.11±0.66^e^   5.22±0.71^f^
  36                     4.00±0.77^a^       4.11±0.86^b^   4.23±0.59^c^   4.32±0.61^d^   4.44±0.50^e^   4.59±0.62^f^
  42                     3.87±0.76^a^       3.99±0.44^b^   4.12±0.51^c^   4.25±0.65^d^   4.33±0.45^e^   4.47±0.56^f^
  48                     3.41±0.81^a^       3.52±0.52^b^   3.66±0.45^c^   3.74±0.50^d^   3.89±0.67^e^   3.97±0.40^f^

^\*^Each value is the mean±standard deviation (*n*= 60) of triplicate experiments. Values in the same column not sharing common superscripts are significantly different among doses (*P*\<0.05).

###### Respiratory frequencies (gill cover movements) during clove-oil-induced anesthesia in the marine medaka, *Oryzias dancena*, in a simulated transport experiment

  Exposuretime (hours)   Dose (mgL^-1^)\*                                                           
  ---------------------- ------------------ ------------- ------------- ------------- ------------- ------------
  6                      128±5.77^a^        125±6.91^b^   117±5.64^c^   105±4.13^d^   98±6.22^e^    91±5.93^f^
  12                     135±4.48^a^        130±4.11^b^   123±6.13^c^   117±6.44^d^   106±7.41^e^   98±4.66^f^
  18                     129±5.31^a^        125±4.38^b^   114±5.55^c^   107±4.77^d^   98±5.58^e^    93±6.38^f^
  24                     125±3.75^a^        121±5.43^b^   112±6.72^c^   101±6.98^d^   96±5.81^e^    88±4.96^f^
  30                     117±6.75^a^        108±6.88^b^   101±7.42^c^   97±7.39^d^    88±6.13^e^    77±6.88^f^
  36                     110±5.13^a^        101±8.86^b^   99±4.99^c^    92±7.06^d^    84±3.65^e^    75±7.13^f^
  42                     109±4.39^a^        100±6.54^b^   98±5.61^c^    85±6.51^d^    81±4.09^e^    72±6.88^f^
  48                     108±5.81^a^        98±4.22^b^    96±6.75^c^    84±7.01^d^    79±6.12^e^    67±5.43^f^

^\*^Each value is the mean±standard deviation (*n*= 60) of triplicate experiments. Values in the same column not sharing common superscripts are significantly different among doses (*P*\<0.05).

###### Ammonium concentrations during clove-oil-induced anesthesia in the marine medaka, *Oryzias dancena*, in a simulated transport experiment

  Exposuretime (hours)   Dose (mgL^-1^)\*                                                               
  ---------------------- ------------------ -------------- -------------- -------------- -------------- --------------
  6                      0.21±0.03^a^       0.17±0.02^b^   0.15±0.04^c^   0.14±0.05^d^   0.11±0.03^e^   0.07±0.01^f^
  12                     0.32±0.09^a^       0.27±0.05^b^   0.25±0.04^c^   0.23±0.03^d^   0.21±0.05^e^   0.20±0.04^f^
  18                     0.38±0.04^a^       0.35±0.04^b^   0.33±0.06^c^   0.32±0.03^d^   0.30±0.04^e^   0.28±0.04^f^
  24                     0.44±0.05^a^       0.42±0.07^b^   0.40±0.05^c^   0.37±0.03^d^   0.34±0.05^e^   0.31±0.08^f^
  30                     0.49±0.02^a^       0.46±0.04^b^   0.44±0.05^c^   0.43±0.04^d^   0.41±0.06^e^   0.38±0.07^f^
  36                     0.58±0.07^a^       0.55±0.07^b^   0.52±0.04^c^   0.50±0.06^d^   0.47±0.09^e^   0.43±0.05^f^
  42                     0.64±0.06^a^       0.61±0.05^b^   0.59±0.07^c^   0.56±0.03^d^   0.52±0.05^e^   0.50±0.07^f^
  48                     0.69±0.01^a^       0.66±0.05^b^   0.63±0.08^c^   0.60±0.09^d^   0.57±0.05^e^   0.54±0.08^f^

^\*^Each value is the mean±standard deviation (*n*= 60) of triplicate experiments. Values in the same column not sharing common superscripts are significantly different among doses (*P*\<0.05).

![Carbon dioxide (CO~2~) concentrations during clove-oil-induced anesthesia in the marine medaka, *Oryzias dancena*, in a simulated transport experiment.\
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The results for the DO concentrations, respiratory frequencies, and NH~4~^+^ and CO~2~ concentrations in the lidocaine-HCl-administered groups are presented in [Tables 6](#T6){ref-type="table"}, [7](#T7){ref-type="table"}, and [8](#T8){ref-type="table"} and [Fig. 4](#F4){ref-type="fig"}, respectively. The DO concentrations and respiratory frequencies decreased up to 48 hours in all experimental groups (*P\<*0.05; [Tables 6](#T6){ref-type="table"} and [7](#T7){ref-type="table"}, respectively), whereas the NH~4~^+^ and CO~2~ concentrations increased up to 48 hours in all the experimental groups (both *P\<*0.05; [Table 8](#T8){ref-type="table"}, [Fig. 4](#F4){ref-type="fig"}). At 6 hours, the DO, NH~4~^+^, and CO~2~ concentrations and the respiratory frequencies had all decreased with increasing lidocaine-HCl concentrations (*P\<*0.05). The CO~2~ concentration at 6 hours was 12.1±2.83 ppm for the control group, 11.4±3.57 ppm for the 20 ppm lidocaine-HCl group, 9.7±2.39 ppm for the 40 ppm lidocaine-HCl group, 8.2±2.12 ppm for the 60 ppm lidocaine-HCl group, 7.5±1.68 ppm for the 80 ppm lidocaine-HCl group, and 7.1±1.84 ppm for the 100 ppm lidocaine-HCl group. At 12 hours, the DO, NH~4~^+^, and CO~2~ concentrations and the respiratory frequencies had all decreased with increasing lidocaine-HCl concentrations. The CO~2~ concentration at 12 hours was 15.4±2.95 ppm for the control group, 14.8±2.51 ppm for the 20 ppm lidocaine-HCl group, 14.2±2.15 ppm for the 40 ppm lidocaine-HCl group, 13.4±3.64 ppm for the 60 ppm lidocaine-HCl group, 12.6±2.11 ppm for the 80 ppm lidocaine-HCl group, and 12.0±1.15 ppm for the 100 ppm lidocaine-HCl group. At all other times (18, 24, 30, 36, 42, and 48 hours), the trends in the DO, NH~4~^+^, and CO~2~ concentrations and respiratory frequencies for the control and lidocaine-HCl-administered groups were similar to those at 6 and 12 hours.

###### Dissolved oxygen concentrations during lidocaine-HCl-induced anesthesia in the marine medaka, *Oryzias dancena*, in a simulated transport experiment

  Exposuretime (hours)   Dose (mgL^-1^)\*                                                               
  ---------------------- ------------------ -------------- -------------- -------------- -------------- --------------
  6                      6.51±0.83^a^       6.66±0.88^b^   6.76±0.74^c^   6.88±0.70^d^   6.97±0.52^e^   7.45±0.89^f^
  12                     6.04±0.79^a^       6.14±0.55^b^   6.24±0.88^c^   6.35±0.65^d^   6.41±0.87^e^   6.59±0.96^f^
  18                     5.46±0.94^a^       5.56±0.86^b^   5.67±0.95^c^   5.78±0.76^d^   5.85±0.91^e^   5.98±1.02^f^
  24                     5.01±0.75^a^       5.14±0.45^b^   5.23±0.57^c^   5.34±0.86^d^   5.45±0.90^e^   5.56±0.88^f^
  30                     4.67±0.92^a^       4.77±0.58^b^   4.89±0.79^c^   4.99±0.93^d^   5.13±0.98^e^   5.28±0.91^f^
  36                     4.00±0.77^a^       4.13±0.81^b^   4.25±0.69^c^   4.40±0.78^d^   4.45±1.05^e^   4.58±0.88^f^
  42                     3.87±0.76^a^       3.97±0.47^b^   4.15±0.81^c^   4.28±0.77^d^   4.37±1.01^e^   4.49±0.94^f^
  48                     3.41±0.81^a^       3.51±0.52^b^   3.67±0.45^c^   3.78±0.56^d^   3.91±0.91^e^   3.99±0.80^f^

^\*^Each value is the mean±standard deviation (*n*= 60) of triplicate experiments. Values in the same column not sharing common superscripts are significantly different among doses (*P\<*0.05).

###### Respiratory frequencies (gill cover movements) during lidocaine-HCl-induced anesthesia in the marine medaka, *Oryzias dancena*, in a simulated transport experiment

  Exposuretime (hours)   Dose (mgL^-1^)\*                                                           
  ---------------------- ------------------ ------------- ------------- ------------- ------------- ------------
  6                      127±5.57^a^        124±6.76^b^   116±5.64^c^   104±4.13^d^   98±7.25^e^    92±5.93^f^
  12                     134±4.67^a^        129±4.25^b^   121±6.13^c^   115±6.44^d^   106±8.14^e^   97±4.66^f^
  18                     127±5.77^a^        123±4.86^b^   112±5.55^c^   106±4.77^d^   98±6.76^e^    91±6.38^f^
  24                     124±3.16^a^        118±5.36^b^   109±6.72^c^   100±6.98^d^   96±6.11^e^    87±4.96^f^
  30                     116±6.19^a^        107±6.64^b^   100±7.42^c^   94±7.39^d^    88±5.12^e^    75±6.88^f^
  36                     109±5.76^a^        100±8.27^b^   98±4.99^c^    90±7.06^d^    85±6.78^e^    74±7.13^f^
  42                     105±4.09^a^        97±6.86^b^    96±5.61^c^    83±6.51^d^    80±7.12^e^    71±6.88^f^
  48                     100±5.14^a^        98±4.27^b^    94±6.75^c^    80±7.01^d^    78±8.20^e^    66±5.43^f^

^\*^Each value is the mean±standard deviation (*n*= 60) of triplicate experiments. Values in the same column not sharing common superscripts are significantly different among doses (*P*\<0.05).

###### Ammonium concentrations during lidocaine-HCl-induced anesthesia in the marine medaka, *Oryzias dancena*, in a simulated transport experiment

  Exposuretime (hours)   Dose (mgL^-1^)\*                                                               
  ---------------------- ------------------ -------------- -------------- -------------- -------------- --------------
  6                      0.21±0.03^a^       0.17±0.02^b^   0.15±0.04^c^   0.13±0.05^d^   0.11±0.03^e^   0.07±0.01^f^
  12                     0.32±0.09^a^       0.25±0.05^b^   0.24±0.04^c^   0.22±0.03^d^   0.20±0.05^e^   0.18±0.04^f^
  18                     0.38±0.04^a^       0.34±0.04^b^   0.32±0.06^c^   0.30±0.03^d^   0.28±0.04^e^   0.26±0.04^f^
  24                     0.44±0.05^a^       0.40±0.07^b^   0.38±0.05^c^   0.36±0.03^d^   0.33±0.05^e^   0.30±0.08^f^
  30                     0.49±0.02^a^       0.45±0.04^b^   0.43±0.05^c^   0.42±0.04^d^   0.40±0.06^e^   0.37±0.07^f^
  36                     0.58±0.07^a^       0.54±0.07^b^   0.51±0.04^c^   0.50±0.06^d^   0.47±0.09^e^   0.44±0.05^f^
  42                     0.64±0.06^a^       0.60±0.05^b^   0.57±0.07^c^   0.55±0.03^d^   0.52±0.05^e^   0.48±0.07^f^
  48                     0.69±0.01^a^       0.64±0.05^b^   0.62±0.08^c^   0.58±0.09^d^   0.55±0.05^e^   0.53±0.08^f^

^\*^Each value is the mean±standard deviation (*n*= 60) of triplicate experiments. Values in the same column not sharing common superscripts are significantly different among doses (*P*\<0.05).

![Carbon dioxide (CO~2~) concentrations during lidocaine-HCl-induced anesthesia in the marine medaka, *Oryzias dancena*, in a simulated transport experiment.\
Each value is the mean±standard deviation (*n*= 60) of triplicate experiments. Values in the same column not sharing common superscripts are significantly different among doses (*P*\<0.05).](dr-21-1-19-g4){#F4}

DISCUSSION {#sec04}
==========

Study results indicate that the higher the concentration of anesthetic at each salinity, the shorter the anesthesia time at each salinity. The patterns of clove oil and lidocaine-HCl observed in the marine medaka are similar to previous studies on other bony fishes such as the sockeye salmon, *Oncorhynchus nerka*, ([@B28]) the rock bream, *Oplegnthus fasciatus* ([@B21]), the greenling, *Hexagrammos otakii* ([@B17]), and the winter flounder, *Pleuronectes americanus* ([@B16]). The dose response of the marine medaka to clove oil and lidocaine-HCl presented a negative exponential curve, with increased doses resulting in decreased time until the anesthesia stage A6.

Optimum anesthetic concentrations are usually expected to induce anesthesia within 3 min and recovery within 10 min ([@B24]; [@B17]). For this study, it was decided that the optimum anesthesia concentration should be at about 1 min. Considering that the optimal anesthesia time is around 1 min, concentrations of clove oil for the marine medaka were 150 ppm at 0 ppt, 20 ppt, and 30 ppt, and 100 ppm at 10 ppt. The optimal anesthesia concentrations of lidocaine-HCl on the marine medaka were 800 ppm and 700 ppm at 0 ppt and 10 ppt, respectively. At 10 ppt, the optimum anesthetic concentration of clove oil and lidocaine-HCl for the marine medaka was similar to that found in a previous study on the marine medaka and water temperature ([@B20]). [@B20] also reported that the optimum anesthetic concentration of both anesthetics at 26 ℃ was 100 ppm and 700 ppm, respectively.

If the ratio of recovery time to anesthetic time is greater than 1, the recovery time is longer than the anesthesia time. For the clove oil, the ratio is less than 1 at 50 ppm, 100 ppm in 20 ppt, 30 ppt and 40 ppt. Other data were recorded greater than 1 and, at each water salinity, the ratio of recovery time to anesthesia time increased as the anesthesia concentration was increased (*P\<*0.05). That is, anesthesia time was shortened as anesthesia concentration increased, but recovery time increased relatively. On the contrary, anesthesia time increased as anesthesia concentration was reduced, but recovery time was shortened relatively (*P\<*0.05). A similar result was reported for the rock bream ([@B21]) in that the increment of clove oil concentration corresponds to the increment of ratio of recovery time to anesthesia time. For lidocaine-HCl, the ratio is less than 1 at 200 ppm in 30 ppt and 40 ppt. Other ratios of recovery time to anesthesia time are greater than 1. This means that recovery time is longer than the anesthesia time for lidocaine-HCl. No other specific regulation was found from this result.

For specific details of this research, anesthesia time and recovery time were fastest at 10 ppt. Anesthesia of fish is accomplished through the gills. High metabolism causes rapid breathing. If metabolism is high, the anesthesia is absorbed faster through the gills ([@B26]). Thus, metabolism of the marine medaka at 10 ppt is expected to be higher than at any other salinity. Results show that anesthetic time and recovery time at 10 ppt are faster than other salinities for further confirmation, comparative physiology research needs to be undertaken to determine these details.

The patterns of DO decline in the water of the control groups, the clove-oil-administered groups, and the lidocaine-HCl-administered groups are consistent with the trends reported in studies of *Rhynchocypris steindachneri*, olive flounder, *Paralichthys olivaceus*, and winter flounder, *Pleuronectes americanus* ([@B13]; [@B18]; [@B21]). Based on these results, we can assume that the high oxygen consumption during the early stage of transportation is attributable to the high levels of stress induced by handling or netting. The results of this study are similar to those of a transportation experiment by [@B3], in which benzocaine-HCl was used as an anesthetic for the Java tilapia, *Oreochromis mossambicus*. In general, both studies showed a reduction in fish metabolism after the application of the anesthetic, which is an indication of declining oxygen consumption. In this study, there seemed to be a positive relationship between the concentrations of lidocaine-HCl and DO, insofar as the group treated with the highest concentration of anesthetic exhibited the smallest decline in DO ([@B3]). A similarly designed experiment by [@B18], with *R. steindachneri* as the test organism, showed that the trends in DO and ventilation rates exhibited the same patterns for 2 h as were observed for 3 h in our study. [@B18] used lower lidocaine-HCl concentrations (5, 10, and 20 ppm), but at a lower temperature (18℃ compared with the 26℃ we used in this experiment), which ultimately produced nearly identical trends. This is an important comparison, because it indicates the wide-ranging effects of lidocaine-HCl over a broad spectrum of temperatures.

[@B7] performed a transportation experiment on the playfish, *Xiphophorus maculatus* (Günther), treated with three different anesthetics: 2-phenoxyethanol (200 ppm), quinaldine sulfate (10 ppm), and MS-222 (30 ppm). At 16 hours after the administration of the anesthetic, the NH~4~^+^ concentration in the water of the 2-phenoxyethanol group was only 65% that of the control group, 20% that of the quinaldine sulfate group, and relatively lower concentration compared with that of the MS-222 group. The trends in ammonium concentrations exhibited by the five experimental groups were consistent with the trends reported by Park et al. ([@B18], [@B21]) and [@B7]. Our conclusions are in accord with those of Park et al. ([@B18], [@B21]), insofar as the overall reduction in NH~4~^+^ excretion was directly related to the anesthetic-induced decline in metabolism.

Lidocaine-HCl induced the expected anesthetic effects for teleost fish in terms of their increased sedation, which is associated with a reduced metabolic rate and reduced oxygen consumption, together with reduced production of both NH~4~^+^ and CO~2~ ([@B14]; [@B18], [@B16], [@B21]). Currently, MS-222 remains the only fish anesthetic approved by the FDA for the United States ([@B23]). However, fish treated with MS-222 are not edible until 21 days after its administration, which is the withdrawal period required for traces of the chemical to disappear from the flesh of the fish ([@B1]). This clearly raises operational issues because the fish cannot be harvested for three weeks.

This study shows that clove oil and lidocaine-HCl are effective techniques for anesthetizing the marine medaka. Moreover, the relationship between anesthetic effect and water salinity was examined. The two anesthetics used in this study meet the requirements of an ideal anesthesia with 3 min anesthesia times and 5 min recovery time. As mentioned by [@B20], the anesthetic effect is significantly affected by the water temperature and the clove oil or lidocaine-HCl concentration, and decreases proportionally as the clove oil or lidocaine-HCl concentration or water temperature increases. The results of [@B20] suggest that the anesthetic effects of clove oil are similar to those of lidocaine-HCl. The results of our experiment suggest that clove oil and lidocaine-HCl both reduce the metabolic activity of the marine medaka, *Oryzias dancena*, thus reducing its ammonium excretion and its oxygen consumption. Both anesthetics are cost-effective, efficient, safe and non-toxic to the fish and the user ([@B17]).

[@B19] reported that the operculum movement number increased under heat anesthesia and cold anesthesia by changing temperature. With anaesthetization at either 38°C or 8°C, the whole-body cortisol level was highest at 0 hour and decreased gradually until 6 hours, whereas the whole-body glucose level was highest at 1 hour and decreased until 2 hours ([@B19]). In conclusion, clove oil and lidocaine-HCl have been shown to be effective anesthetics, improving the transportation of the marine medaka. Results from this study will contribute to safe laboratory handling of the marine medaka, which are commonly required for use by many research studies and experiments. The results of our study should be useful for aquaculturists and transporters who require that minimal stress is imposed on fish during transport. In this study, we were not analyzed change of physiological response by clove oil and lidocaine-HCl anesthesia. So, future investigations on the marine medaka should focus on comparative analysis of physiological reactions by salinity and anesthetics.

This research was supported by a research grant (RP-2012-AQ-045) from the National Fisheries Research and Development Institute, Korea. The authors would like to thank anonymous editors for their helpful suggestions that improved the quality of this paper. We declare that all experiments in this study comply with the current laws of Korea.
